University of Oxford, U.K.
Findings from the United Kingdom, Belgium and United States describe new data in HIV/AIDS research
Published in AIDS Weekly and Law, September 7th, 2006
Study 1: A prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 gag coupled to CD8+ T-cell epitopes induced multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects.
Researchers writing in the Journal of Virology report, "A double-blind randomized phase 1 trial was conducted in human immunodeficiency virus type 1 (HIV-1)-negative subjects receiving vaccines vectored by plasmid DNA and modified vaccinia virus Ankara (MVA) expressing HIV-1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
Source: AIDS Weekly and Law (2006-09-07)
More Articles from AIDS Weekly and Law
- Beijing Union Medical College Hospital, Beijing, People's Republic of China
Correlation between CD8 responses and HIV RNA or CD4 count not consistent throughout infection - Business & Finance
Allion Healthcare posts 81.8% increase in net sales - Cure Autism Now
Cure Autism celebrates Senate approval of Combating Autism Act of 2006 - Cure HIV
Cure HIV, Inc. and Global Humanceuticals, Inc. seek international patent on drug to combat HIV/AIDS - Prince Leopold Institute of Tropical Medicine, Belgium
Clinical criteria alone identify HIV-infected patients who need HAART - Skin & Cancer Foundation, Australia
Allergic contact dermatitis to basic red 46 occurred in HIV/AIDS - More from this issue of AIDS Weekly and Law
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
